VIRASTAT FITC-LABELED ANTI-INFLUENZA A AND B MONOCLONAL ANTIBODIES

Antisera, Neutralization, Influenza Virus A, B, C

ZYMETX, INC.

The following data is part of a premarket notification filed by Zymetx, Inc. with the FDA for Virastat Fitc-labeled Anti-influenza A And B Monoclonal Antibodies.

Pre-market Notification Details

Device IDK984596
510k NumberK984596
Device Name:VIRASTAT FITC-LABELED ANTI-INFLUENZA A AND B MONOCLONAL ANTIBODIES
ClassificationAntisera, Neutralization, Influenza Virus A, B, C
Applicant ZYMETX, INC. 800 RESEARCH PKWY., SUITE 100 Oklahoma City,  OK  73104
ContactCraig D Shimasaki
CorrespondentCraig D Shimasaki
ZYMETX, INC. 800 RESEARCH PKWY., SUITE 100 Oklahoma City,  OK  73104
Product CodeGNR  
CFR Regulation Number866.3330 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-12-28
Decision Date1999-03-04
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.